| Dr Clara Stringer-auld, MD | |
|
34 Butler Pl, Apartment #11, Brooklyn, NY 11238-5142 | |
| (646) 239-7129 | |
| Not Available |
| Full Name | Dr Clara Stringer-auld |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 34 Butler Pl, Brooklyn, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578556866 | NPI | - | NPPES |
| 02787795 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 226429 (New York) | Primary |
| Entity Name | Hospitalist Healthcare Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275962011 PECOS PAC ID: 1557599313 Enrollment ID: O20140124001195 |
News Archive
More than 90 million Americans can sigh comfortably because of new relief for their bad breath. Dental experts today revealed research highlighting a new treatment option that can eliminate halitosis or chronic bad breath at the Academy of General Dentistry's (AGD) 53rd Annual Meeting in Washington, D.C.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.
Sub-Saharan African countries that train and invest in their doctors end up losing billions of dollars as the clinicians leave to work in developed nations, finds research published on bmj.com today.
In a research paper recently uploaded to the preprint server bioRxiv by Harbison et al. (April 1st 2021) a set of multi-microsecond long molecular dynamics simulations study the effects of altering glycosylation at sites N234, N165, N343, and the newly identified ancestral site N370, uncovering the influence of these sites on infectivity.
A century ago this month, German psychiatrist Alois Alzheimer formally described characteristics of the neurodegenerative disease which ultimately came to bear his name. While international efforts to learn about Alzheimer's disease and develop treatments have progressed significantly in recent years, a cure remains an elusive goal.
› Verified 9 days ago
| Entity Name | New York General Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700315538 PECOS PAC ID: 7810255494 Enrollment ID: O20180103003151 |
News Archive
More than 90 million Americans can sigh comfortably because of new relief for their bad breath. Dental experts today revealed research highlighting a new treatment option that can eliminate halitosis or chronic bad breath at the Academy of General Dentistry's (AGD) 53rd Annual Meeting in Washington, D.C.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.
Sub-Saharan African countries that train and invest in their doctors end up losing billions of dollars as the clinicians leave to work in developed nations, finds research published on bmj.com today.
In a research paper recently uploaded to the preprint server bioRxiv by Harbison et al. (April 1st 2021) a set of multi-microsecond long molecular dynamics simulations study the effects of altering glycosylation at sites N234, N165, N343, and the newly identified ancestral site N370, uncovering the influence of these sites on infectivity.
A century ago this month, German psychiatrist Alois Alzheimer formally described characteristics of the neurodegenerative disease which ultimately came to bear his name. While international efforts to learn about Alzheimer's disease and develop treatments have progressed significantly in recent years, a cure remains an elusive goal.
› Verified 9 days ago
| Entity Name | Nv Pacs 2 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427534809 PECOS PAC ID: 0941550578 Enrollment ID: O20210831002021 |
News Archive
More than 90 million Americans can sigh comfortably because of new relief for their bad breath. Dental experts today revealed research highlighting a new treatment option that can eliminate halitosis or chronic bad breath at the Academy of General Dentistry's (AGD) 53rd Annual Meeting in Washington, D.C.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.
Sub-Saharan African countries that train and invest in their doctors end up losing billions of dollars as the clinicians leave to work in developed nations, finds research published on bmj.com today.
In a research paper recently uploaded to the preprint server bioRxiv by Harbison et al. (April 1st 2021) a set of multi-microsecond long molecular dynamics simulations study the effects of altering glycosylation at sites N234, N165, N343, and the newly identified ancestral site N370, uncovering the influence of these sites on infectivity.
A century ago this month, German psychiatrist Alois Alzheimer formally described characteristics of the neurodegenerative disease which ultimately came to bear his name. While international efforts to learn about Alzheimer's disease and develop treatments have progressed significantly in recent years, a cure remains an elusive goal.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clara Stringer-auld, MD 34 Butler Pl, Apartment #11, Brooklyn, NY 11238-5142 Ph: () - | Dr Clara Stringer-auld, MD 34 Butler Pl, Apartment #11, Brooklyn, NY 11238-5142 Ph: (646) 239-7129 |
News Archive
More than 90 million Americans can sigh comfortably because of new relief for their bad breath. Dental experts today revealed research highlighting a new treatment option that can eliminate halitosis or chronic bad breath at the Academy of General Dentistry's (AGD) 53rd Annual Meeting in Washington, D.C.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.
Sub-Saharan African countries that train and invest in their doctors end up losing billions of dollars as the clinicians leave to work in developed nations, finds research published on bmj.com today.
In a research paper recently uploaded to the preprint server bioRxiv by Harbison et al. (April 1st 2021) a set of multi-microsecond long molecular dynamics simulations study the effects of altering glycosylation at sites N234, N165, N343, and the newly identified ancestral site N370, uncovering the influence of these sites on infectivity.
A century ago this month, German psychiatrist Alois Alzheimer formally described characteristics of the neurodegenerative disease which ultimately came to bear his name. While international efforts to learn about Alzheimer's disease and develop treatments have progressed significantly in recent years, a cure remains an elusive goal.
› Verified 9 days ago
Dr. Alexander Usorov, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 447 Atlantic Ave, Brooklyn, NY 11217 Phone: 718-858-6300 | |
Dr. Marcellus Andre Walker, MD Geriatric Medicine Medicare: May Accept Medicare Assignments Practice Location: 2094 Pitkin Ave, Brooklyn, NY 11207 Phone: 718-240-0516 Fax: 718-240-0564 | |
Lotus Ahmed, D.O Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 518 Mcdonald Ave, Brooklyn, NY 11218 Phone: 917-848-5432 Fax: 347-252-6754 | |
Mrs. Sophia Schwartzman, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Ocean Avenue, Brooklyn, NY 11229 Phone: 518-587-1141 | |
Dr. Haitham M Ahmed, MD, MPH Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Pennsylvania Avenue, Brooklyn, NY 11207 Phone: 718-240-2000 Fax: 718-240-2260 | |
Yanjin Yang, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-3000 | |
Ashwad Afzal, M.D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-5246 |